Ann-Margret Ervin

Ann-Margret Ervin

Assistant Scientist

Departmental Affiliation(s):

Epidemiology (Primary)
School of Medicine (Joint)

Contact Information

615 N. Wolfe Street, E6146
Baltimore , Maryland   21205
US        

410.502.4633

Education

PhD, Johns Hopkins University, 2006
MPH, Emory University

Overview

Dr. Ervin’s research interests focus on the comparative effectiveness of interventions to treat and prevent ocular disease and visual impairment.  She is currently the Co-Principal Investigator of the Data Coordinating Center for a multicenter natural history study of Stargardt Disease with colleagues at the Wilmer Eye Institute. She was recently the Co-Principal investigator of a project funded by the Johns Hopkins Evidence-Based Practice Center and the Agency for Healthcare Research and Quality to prepare a comparative effectiveness review of screening methods and medical and surgical treatment for chronic open-angle glaucoma.   Dr. Ervin has a long term interest in the design and conduct of randomized clinical trials and has worked on numerous studies of the causes, prevention, diagnosis or treatment of disorders of the eye and visual system including age-related macular degeneration, refractive error, low vision, cataract, and diabetic retinopathy. Other research interests include the impact of US federal regulations for institutional review boards (IRBs) on ethical review of multicenter clinical trials and the advantages and disadvantages of alternate IRB review models for streamlining the review process in the multicenter setting.

Honors and Awards

Clinical Trials Training Program in Vision Research Fellowship, National Eye Institute, Johns Hopkins Bloomberg School of Public Health Dean’s Scholar Academic Scholarship, Emory University

Research Interests

epidemiology, clinical trials, clinical trials methodology, visual impairment, eye disease, ophthalmology, optometry, research ethics, ethics and institutional review boards

Publications

  •   Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} Boland MV, Ervin AM, Friedman D, Jampel H, Hawkins B, Vollenweider D, Chelladurai Y, Ward D, Suarez-Cuervo C, Robinson KA Comparative Effectiveness of Treatments for Open-Angle Glaucoma: A Systematic Review. Annals of Internal Medicine 2013;158:271-279
  • Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 Ervin AM, Boland MV, Myrowitz E, Prince J, Hawkins B, Vollenweider D, Ward D, Suarez-Cuervo C, Robinson KA. Comparative Effectiveness of Screening for Glaucoma. Comparative Effectiveness Review No. 59.  AHRQ Publication No. 12-EHC037-EF. Rockville, MD: Agency for Healthcare Research and Quality. 12 April 2012.PMID: 22649799 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";}
  •   Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} Mathew MC, Ervin AM, Tao J, Davis RM. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No.: CD004567. DOI: 10.1002/14651858.CD004567.pub2  
  • Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} Ervin AM, Wojciechowski R, Schein O. Punctal occlusion for dry eye syndrome (Review). Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD006775. DOI: 10.1002/14651858.CD006775.pub2  
  • Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 Ervin A. Motivating authors to update systematic reviews: Practical strategies from a behavioural science perspective. Paediatric and Perinatal Epidemiology, 2008; 22 (Suppl. 1): 33-37 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";}